866-997-4948(US-Canada Toll Free)

Subcutaneous Immunoglobulin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Published By :

Transparency Market Research

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 145 Pages

Global Subcutaneous Immunoglobulin Market: Overview

Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are defective. PIDDs are thus often characterized by increased vulnerability to infections. According to the International Union of Immunological Societies (IUIS), PIDD is a compilation of more than 150 different diseases.

Global Subcutaneous Immunoglobulin Market: Research Methodology

This report on the subcutaneous immunoglobulin market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year.

Market related factors such as technological developments, product innovation, expansion of healthcare infrastructure facilities around the world, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the subcutaneous immunoglobulin market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Global Subcutaneous Immunoglobulin Market: Segmentation

On the basis of application, the subcutaneous immunoglobulin market is categorized into primary immunodeficiency diseases, secondary immunodeficiency diseases and others. In terms of end users, the subcutaneous immunoglobulin market is segmented into hospitals, home care and clinics.

On the basis of geography, the subcutaneous immunoglobulin market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America comprises the U.S. and Canada. Europe comprises Germany, France, U.K., Spain, Italy and Rest of Europe. Asia-Pacific comprises China, India, Japan, Australia and New Zealand and Rest of Asia Pacific. Latin America comprises Brazil, Mexico and Rest of Latin America.  Middle East & Africa comprises of GCC Countries, South Africa and Rest of Middle East & Africa.

Global Subcutaneous Immunoglobulin Market: Competitive Dynamics

The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the subcutaneous immunoglobulin market. The report also profiles major players in the subcutaneous immunoglobulin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Grifols S.A., CSL Behring LLC, Shire Plc., Biotest AG, Kedrion S.p.A., Octapharma AG, Baxalta Incorporated and Talecris Biotherapeutics, Inc.

The Subcutaneous Immunoglobulin market has been segmented as follows:         

Global Subcutaneous Immunoglobulin Market, by Application

  • Primary Immunodeficiency Diseases
  • Secondary Immunodeficiency Diseases
  • Others

Global Subcutaneous Immunoglobulin Market, by End User

  • Hospitals
  • Clinics
  • Home Care

Global Subcutaneous Immunoglobulin Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of MEA 

Table of Content

Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Subcutaneous Immunoglobulin (SCIG): Market Snapshot
3.2 Market Share Analysis by Region, 2015
3.3 Global Subcutaneous Immunoglobulin (SCIG) Market : Opportunity Map

Section 4 Market Overview
4.1 Indication Overview
4.2 Global Subcutaneous Immunoglobulin (SCIG) Market : Key Industry Developments
4.3 Global Subcutaneous Immunoglobulin (SCIG) Market : Market Indicators

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Rise in prevalence of autoimmune disorders
5.2.2 Increase in global geriatric population
5.2.3 Growing usage in off-label indications
5.2.4 Improved technology for production and purification methods
5.2.5 Favorable government initiatives and approvals
5.2.6 Increased convenience and patient satisfaction for SCIG compared to IVIG
5.3 Restraints
5.3.1 High cost of treatment
5.3.2 Supply demand gaps
5.4 Global Subcutaneous Immunoglobulin (SCIG) Market : Opportunity Analysis
5.5 Opportunities
5.5.1 Innovations in administration of subcutaneous immunoglobulin
5.5.2 Increasing global plasma yield to offer significant opportunities to new entrants
5.6 Key Trends
5.7 Porter’s Analysis
5.8 Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2014–2024
5.9 Value Chain Analysis
5.10 Subcutaneous Immunoglobulin (SCIG) Market Outlook

Section 6 Subcutaneous Immunoglobulin (SCIG) Market Analysis, by Application
6.1 Key Findings
6.2 Introduction
6.3 Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
6.4 Global Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application
6.5 Global Subcutaneous Immunoglobulin (SCIG) Market Analysis, by Application (1/2)
6.5.1 Primary Immunodeficiency Diseases
6.5.2 Secondary Immunodeficiency Diseases
6.5.3 Others
6.6 Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application
6.7 Key Trends

Section 7 Subcutaneous Immunoglobulin (SCIG) Market Analysis, by End-user
7.1 Key Findings
7.2 Introduction
7.3 Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
7.4 Global Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
7.4.1 Hospitals
7.4.2 Clinics
7.4.3 Homecare Settings
7.5 Market Attractiveness Analysis, by End-user
7.6 Key Trends

Section 8 Subcutaneous Immunoglobulin (SCIG) Market Analysis, by Region
8.1 Global Subcutaneous Immunoglobulin (SCIG) Market Snapshot, by Country
8.2 Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Region
8.3 Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Region
8.4 Market Attractiveness Analysis, by Region

Section 9 North America Subcutaneous Immunoglobulin (SCIG) Market Analysis
9.1 Key Findings
9.2 Market Overview
9.3 North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
9.4 North America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application
9.5 North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
9.6 North America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
9.7 North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
9.8 North America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
9.9 North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis
9.10 Market Trends

Section 10 Europe Subcutaneous Immunoglobulin (SCIG) Market Analysis
10.1 Key Findings
10.2 Market Overview
10.3 Europe Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
10.4 Europe Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application
10.5 Europe Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
10.6 Europe Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
10.7 Europe Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
10.8 Europe Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
10.9 Europe Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis
10.10 Market Trends

Section 11 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Analysis
11.1 Key Findings
11.2 Market Overview
11.3 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
11.4 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application
11.5 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
11.6 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
11.7 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
11.8 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
11.9 Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis
11.10 Market Trends

Section 12 Latin America Subcutaneous Immunoglobulin (SCIG) Market Analysis
12.1 Key Findings
12.2 Market Overview
12.3 Latin America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
12.4 Latin America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application
12.5 Latin America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
12.6 Latin America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
12.7 Latin America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
12.8 Latin America Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
12.9 Latin America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis
12.10 Market Trends

Section 13 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Analysis
13.1 Key Findings
13.2 Market Overview
13.3 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application
13.4 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Application
13.5 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user
13.6 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Forecast, by End-user
13.7 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country
13.8 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Forecast, by Country
13.9 Middle East & Africa Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis
13.10 Market Trends

Section 14 Competition Landscape
14.1 Global Subcutaneous Immunoglobulin Market Share Analysis, By Company, (2016)
14.2 Competition Matrix
14.3 Competition Landscape
14.3.1 Baxalta Incorporated
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.1.4 Financial Overview
14.3.1.5 Strategic Overview
14.3.2 Biotest AG
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.2.4 Financial Overview
14.3.2.5 Strategic Overview
14.3.3 CSL Behring
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.3.4 Financial Overview
14.3.3.5 Strategic Overview
14.3.4 Grifols, S.A.
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.4.4 Financial Overview
14.3.4.5 Strategic Overview
14.3.5 Talecris Biotherapeutics, Inc.
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.5.4 Financial Overview
14.3.5.5 Strategic Overview
14.3.6 Kedrion S.p.A.
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.6.4 Financial Overview
14.3.6.5 Strategic Overview
14.3.7 Octapharma AG
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.7.4 Financial Overview
14.3.7.5 Strategic Overview
14.3.8 Shire Plc
14.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.8.4 Financial Overview
14.3.8.5 Strategic Overview

List of Table

Table 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 02: Global Subcutaneous Immunoglobulin (IVIG) Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 03: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 04: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 05: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 06: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 07: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 08: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 09: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 10: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 11: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 12: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 13: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 14: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 15: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 16: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2016–2024
Table 17: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 18: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country, 2014–2024

List of Chart

Figure 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2016–2024
Figure 02: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2016 and 2024
Figure 03: Global Primary Immunodeficiency Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 04: Global Secondary Immunodeficiency Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 05: Global Secondary Immunodeficiency Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
Figure 06: Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application
Figure 07: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2016 and 2024
Figure 08: Global Hospitals Market Revenue, US$ Mn, 
Figure 09: Global Clinics Market Revenue, US$ Mn,
Figure 10: Global Home Care Settings Market Revenue, US$ Mn, 2014–2024
Figure 11: Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user
Figure 12: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Region, 2016 and 2024
Figure 13: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Region
Figure 14: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2016–2024
Figure 15: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country
Figure 16: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2016 and 2024
Figure 17: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2016 and 2024
Figure 18: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country, 2016 and 2024
Figure 19: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application 
Figure 20: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user
Figure 21: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 22: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country
Figure 23: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2016 and 2024
Figure 24: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2016 and 2024
Figure 25: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Country, 2016 and 2024
Figure 26: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application
Figure 27: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user
Figure 28: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2014–2024
Figure 29: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country
Figure 30: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2016 and 2024
Figure 31: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2016 and 2024
Figure 32: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country, 2016 and 2024
Figure 33: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application
Figure 34: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user
Figure 35: Latin America subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2014–2024
Figure 36: Latin America Market Attractiveness Analysis, by Country
Figure 37: Latin America Market Value Share Analysis, by Application, 2016 and 2024
Figure 38: Latin America Market Value Share Analysis, by End-user, 2016 and 2024
Figure 39: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 40: : Latin America Market Attractiveness Analysis, by Application
Figure 41: : Latin America Market Attractiveness Analysis, by End-user
Figure 42: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2014–2024
Figure 43: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country
Figure 44: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2016 and 2024
Figure 45: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2016 and 2024
Figure 46: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Country, 2016 and 2024
Figure 47 : Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application
Figure 48 : Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user
Figure 49: Global Subcutaneous Immunoglobulin (SCIG) Market Share Analysis, by Company (2016)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *